Press release
Heater-Cooler Unit for Surgery Market to Surpass USD 241.6 Million by 2034, Fuelled by Advancements in Cardiothoracic and Transplant Surgeries.
Market OverviewThe global heater-cooler unit for surgery market is projected to reach USD 241.6 million by 2034, up from USD 137.2 million in 2024, growing at a compound annual growth rate (CAGR) of 5.7% over the forecast period (2024-2034).
Heater-cooler units (HCUs) are critical devices that regulate patient body temperature during procedures involving cardiopulmonary bypass, open-heart surgeries, and organ transplants. By maintaining normothermia or inducing hypothermia, these devices reduce complications, preserve organ function, and enhance recovery.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/58893
Key Highlights:
• 2024 Market Size: USD 137.2 Million
• 2034 Forecast Size: USD 241.6 Million
• CAGR (2024-2034): 5.7%
• Applications: Cardiothoracic surgeries, transplants, complex vascular procedures
• Barriers: High cost, infection control concerns, equipment complexity
• Top Players: LivaNova, Getinge, Terumo Corporation, Braile Biomédica, Sorin Group
Segmentation Analysis
By Product Type:
• Standalone Heater-Cooler Units
• Integrated Cardiopulmonary Bypass Systems
• Portable/Compact HCUs
By Application:
• Cardiopulmonary Bypass Surgery
• Organ Transplantation
• Neonatal and Pediatric Surgery
• Complex Vascular Procedures
• Neurosurgery
• Trauma & Emergency Surgery
By End User:
• Hospitals
• Cardiothoracic Surgery Centers
• Ambulatory Surgical Centers (ASCs)
• Research & Teaching Institutions
Segmentation Summary:
Standalone HCUs remain the most widely used due to their versatility and compatibility with a range of surgical setups, while integrated systems are gaining ground in large hospitals for cardiopulmonary bypass. Cardiac surgery remains the dominant application, but organ transplantation and neonatal surgery are emerging as critical use cases. Hospitals and academic centers are the largest end users globally, driving demand for advanced, regulation-compliant systems.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/purchase/?currency=USD&type=single_user_license&report_id=58893
Regional Analysis
North America:
• Leading market, driven by advanced surgical capabilities, high surgical volumes, and well-equipped operating rooms.
• The U.S. accounts for the majority share due to strong investments in cardiac care, rising transplant procedures, and strict regulatory standards (FDA, CDC).
Europe:
• Countries like Germany, France, and the UK are at the forefront due to an established healthcare infrastructure and cardiac surgery excellence centers.
• The EU's push for infection control and safer HCU designs supports regional demand.
Asia-Pacific:
• Fastest-growing region, fueled by rising healthcare access, medical tourism in India and Thailand, and large-scale hospital expansions in China and Japan.
• Increasing prevalence of congenital heart defects and cardiovascular disease adds to procedural volumes requiring HCUs.
Latin America:
• Growing demand from Brazil, Mexico, and Argentina, with improving hospital infrastructure and government-led healthcare reforms.
Middle East & Africa:
• Moderate growth supported by investments in multi-specialty hospitals, especially in the UAE, Saudi Arabia, and South Africa.
Regional Summary:
While North America and Europe dominate the market in terms of technology and installed base, Asia-Pacific is set to experience the highest CAGR through 2034, driven by healthcare modernization and increased demand for complex surgeries.
Market Dynamics
Key Growth Drivers:
• Rising Cardiovascular and Transplant Surgeries: The increasing burden of heart disease, along with greater availability of heart, liver, and kidney transplants, is directly propelling demand for HCUs in operating rooms.
• Technological Advancements: Next-gen HCUs feature digital temperature control, dual reservoir systems, noise reduction, and infection prevention features, enhancing reliability and patient safety.
• Regulatory Pressure for Sterile and Safe Devices: Following past contamination concerns (e.g., Mycobacterium chimaera), regulatory agencies now demand more stringent quality and cleaning protocols, spurring innovation.
• Expansion of Surgical Care in Emerging Economies: Countries in Asia and Latin America are investing in high-acuity hospitals, boosting demand for cardiac surgery equipment including heater-cooler units.
Key Challenges:
• Infection Risk and Regulatory Scrutiny: Improper maintenance or contamination in water circuits can lead to serious post-operative infections, prompting recalls and lawsuits.
• High Equipment Cost and Maintenance Needs: HCUs can be expensive to procure and operate, especially for small and mid-sized hospitals in developing countries.
• Training and Complexity of Use: Operating HCUs safely requires well-trained perfusionists and surgical teams, posing challenges in less specialized care centers.
Emerging Trends:
• Portable and Compact HCUs: Designed for neonatal and field surgery applications, these are growing in demand for their mobility and user-friendliness.
• IoT-Enabled Monitoring: Integration with digital dashboards and EMR systems allows for real-time performance tracking, remote maintenance alerts, and predictive servicing.
• Eco-Friendly Systems: Manufacturers are working on energy-efficient models with sustainable water filtration and reduced footprint.
• Integrated Operating Room Suites: Next-gen surgical rooms are being built with fully connected perfusion systems, including HCUs, for seamless procedural control.
Explore Full Report here: https://exactitudeconsultancy.com/reports/58893/global-heater-cooler-unit-for-surgery-market
Competitor Analysis
Major Companies:
• LivaNova PLC (Sorin Group): A global leader in perfusion and cardiopulmonary bypass systems. Offers flagship heater-cooler units like 3T Heater-Cooler System, with a strong reputation in cardiac ORs.
• Getinge AB (Maquet): Offers advanced CardioSave and Performer HT systems for perfusion and temperature control, known for reliability and innovation.
• Terumo Corporation: Japanese multinational with high-performance Terumo HX2 Heater-Cooler Unit designed for cardiac procedures.
• Braile Biomédica: Strong presence in Latin America with focus on cost-effective and safe cardiopulmonary solutions.
• Stockert GmbH (Part of LivaNova): Known for high-efficiency temperature regulation systems for surgical applications worldwide.
• HeartWare International (Medtronic-acquired): Offers perfusion-related components used in transplant and cardiac care.
• Soma Technology Inc. - Distributor of refurbished HCUs and surgical equipment in the U.S. market.
• Medion Healthcare Pvt. Ltd. - Emerging player in South Asia, offering accessible cardiopulmonary bypass equipment.
• Wego Group (China): Manufacturer offering locally developed HCUs and perfusion circuits for domestic use.
• Sarns (part of Terumo): A pioneer in heart-lung machine components and surgical temperature control.
Competitive Summary:
The competitive landscape is led by LivaNova, Getinge, and Terumo, with a strong focus on product reliability, infection control, and integration with bypass systems. Smaller players are innovating with portable and cost-efficient units for emerging markets. Strategic partnerships with hospitals, regulatory bodies, and training centers are key to expanding market presence.
Conclusion
The global heater-cooler unit for surgery market is set to grow steadily over the next decade, driven by increasing surgical complexity, heightened focus on patient temperature management, and stringent infection control requirements. As healthcare infrastructure expands and technology evolves, HCUs are becoming an essential part of safe, outcome-driven surgical environments.
With a projected value of USD 241.6 million by 2034 and a solid CAGR of 5.7%, the market presents significant opportunities for both established leaders and emerging innovators.
This report is also available in the following languages: Japanese (手術用ヒータークーラーユニット), Korean (수술용 히터-쿨러 장치), Chinese (手术用加热冷却器), French (Unité de chauffage et de refroidissement pour la chirurgie), German (Heiz-Kühl-Einheit für die Chirurgie), and Italian (Unità di riscaldamento e raffreddamento per chirurgia), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/58893/global-heater-cooler-unit-for-surgery-market#request-a-sample
Our More Reports:
Adaptive Cruise Control Market
https://exactitudeconsultancy.com/reports/66856/adaptive-cruise-control-market
Parking Assistance Systems Market
https://exactitudeconsultancy.com/reports/66858/parking-assistance-systems-market
L2+ to L4 Autonomous Driving Solutions Market
https://exactitudeconsultancy.com/reports/66860/l2-to-l4-autonomous-driving-solutions-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heater-Cooler Unit for Surgery Market to Surpass USD 241.6 Million by 2034, Fuelled by Advancements in Cardiothoracic and Transplant Surgeries. here
News-ID: 4114484 • Views: …
More Releases from Exactitiude Consultancy

Non-Muscle Invasive Bladder Cancer Market Industry Analysis by Size, Share, Grow …
Introduction
The Non-Muscle Invasive Bladder Cancer (NMIBC) market is poised for significant growth as advancements in intravesical therapies, immuno-oncology drugs, and molecular diagnostics improve patient outcomes. NMIBC, which accounts for about 70-75% of all newly diagnosed bladder cancer cases, is characterized by high recurrence rates but relatively low mortality compared to muscle-invasive forms. The rising global prevalence, particularly among aging populations, is prompting greater investment in early diagnosis, novel drug delivery…

NK Cell Therapy Market Size And Global Industry Forecast 2034
NK Cell Therapy Market Outlook 2024-2034: Immuno-Oncology Innovation and Off-the-Shelf Therapies Set the Stage for Rapid Growth
Introduction
The Natural Killer (NK) Cell Therapy market is one of the most dynamic segments in immuno-oncology, driven by breakthroughs in cell engineering, off-the-shelf allogeneic therapies, and combination regimens with checkpoint inhibitors. NK cells, part of the innate immune system, have demonstrated strong potential in targeting and destroying cancer cells without prior sensitization, making them…

Neuroendocrine Prostate Cancer Market Size, Share and Growth Report, 2034
Introduction
The Neuroendocrine Prostate Cancer (NEPC) market is emerging as a key focus area in oncology due to its aggressive nature, poor prognosis, and increasing recognition as a distinct clinical entity. NEPC can develop de novo or as a treatment-emergent form of advanced prostate cancer following androgen deprivation therapy (ADT) resistance. While rare, NEPC is challenging to treat, requiring a combination of chemotherapy, targeted agents, and investigational therapies. Rising awareness, advancements…

Metastatic Colorectal Cancer Market Size And Global Industry Forecast 2034
Introduction
The Metastatic Colorectal Cancer (mCRC) market is entering a transformative phase as precision medicine, biomarker-driven treatment strategies, and immunotherapy reshape patient care. Increasing adoption of EGFR inhibitors, VEGF inhibitors, immune checkpoint inhibitors, and combination regimens is improving survival rates, while advancements in molecular diagnostics are enabling more tailored treatment approaches. Over the next decade, continuous R&D efforts and expanded access to innovative therapies are expected to drive market growth.
Download Full…
More Releases for HCU
Homocystinuria Pipeline Overview: Biopharma Innovators Target Novel Approaches t …
The therapeutic landscape for homocystinuria, a rare inherited metabolic disorder caused by deficiencies in enzymes involved in methionine metabolism (most commonly cystathionine beta-synthase), is poised for meaningful evolution. While dietary management, vitamin supplementation, and betaine remain the current standard of care, significant unmet needs persist in preventing serious complications such as vascular events, skeletal abnormalities, and neurological impairment. Emerging treatments aim to go beyond symptomatic management to address underlying metabolic…
Homocystinuria Market Growth to Accelerate in Forecast Period (2023-2032), Delve …
DelveInsight's "Homocystinuria Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Homocystinuria, historical and forecasted epidemiology as well as the Homocystinuria market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Homocystinuria market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Homocystinuria Market Forecast
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the…
Homocystinuria Market is Expected to Expand at a Healthy Growth Rate During the …
DelveInsight's "Homocystinuria Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Homocystinuria, historical and forecasted epidemiology as well as the Homocystinuria market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Homocystinuria market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Homocystinuria Market Forecast
https://www.delveinsight.com/sample-request/homocystinuria-market-new?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the…
Power Electronics Market to See Huge Growth by 2027 | Bosch, BYD, Continental, D …
The Latest research study released by HTF MI “Global Power Electronics Market” with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major Companies covered in this Research…
Future Growth: New Energy Vehicle Power Electronics Market By Key Players: Bosch …
Qyresearchreports include new market research report New Energy Vehicle Power Electronics to its huge collection of research reports.
Power electronics is the application of solid-state electronics to the control and conversion of electric power.
Pushed by aggressive targets in terms of CO2 emissions, electrification is undoubtedly the "greenest" option for car makers to use new energy.
The New Energy Vehicle Power Electronics market was valued at xx Million US$ in 2017 and is…
Global and China Color Doppler HCU Market 2016: Industry Size, Share, Trends, Co …
Global and China Color Doppler HCU Market 2016-2021 Market Research Report
The report on the Global and China Color Doppler HCU Market 2016 Industry meticulously addresses the various drivers, restraints, and opportunities that exist in this space. Compiled by a team of expert analysts, the report offers an overview of the all the key performance indicators of the Global and China Color Doppler HCU Market 2016 Industry.The study analyzes the Global…